Inflammation Clinical Trial
— ALTAXOfficial title:
The Effect of an Increased Intake of Antioxidant-rich Foods on Training Adaptation, Redox-balance and Inflammation Among Elite Athletes During a Moderate Altitude Training Camp
Verified date | March 2017 |
Source | University of Oslo |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Athletes, especially in endurance sports, are at increased risk of oxidative stress and inflammation-related diseases and injuries. The production of reactive oxygen and nitrogen species (RONS) and inflammatory markers increase during exercise and especially during altitude training. Antioxidant supplementation is commonly used among athletes in the belief that it prevents oxidative stress and oxidative damage. A transient increase of RONS is however necessary to activate signaling cascades initiating training adaptation. Antioxidant supplementation has been shown to inhibit the exercise effects in several independent studies, possibly by interfering/reducing the signal cascades initiated by RONS. However, it is unknown whether a high intake of antioxidant rich foods can affect the amount of RONS, inflammation markers and/or training adaptation. The investigators want to examine whether an increased intake of natural antioxidants in the form of antioxidant-rich foods fruits, vegetables and berries, in line with the official Norwegian dietary advice can affect antioxidant status, immune function and training adaptation associated with altitude training in Norwegian elite athletes.
Status | Completed |
Enrollment | 35 |
Est. completion date | November 2015 |
Est. primary completion date | November 2015 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years to 42 Years |
Eligibility |
Inclusion Criteria: - National team athletes, summer endurance sports Exclusion Criteria: - Allergies in conflict with the intervention foods - Use of medication that could affect training and performance - Injuries that could affect training and performance |
Country | Name | City | State |
---|---|---|---|
Norway | Norwegian Olympic Federation | Oslo | |
Norway | University of Oslo | Oslo |
Lead Sponsor | Collaborator |
---|---|
University of Oslo | Norwegian Olympic Federation, Oslo, Norway, Norwegian School of Sport Sciences |
Norway,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percent change in performance (sport specific tests will be aggregated to one outcome by the use of percent change) | Cycling: 10 000 m on a bike roller; Rowing: 2000 meter on Concept2-apparatus; Paddling: 1000 meter Concept2-apparatus; Swimming: 200 meter | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Primary | Training adaptation | change in Vo2-max | Measured one week before, and one week after the moderate altitude training camp | |
Primary | Training adaptation for swimmers | For swimming only: 100 meter max speed | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | Change in biomarkers of inflammation | change in cytokine profile e.g. IL-6 ,TNF, CRP measured by multiplex technology | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | change in lean body mass | measured by DXA (iDXA; GE Healthcare) | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | Bone mineral density | measured by DXA (iDXA; GE Healthcare) | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | change in fat mass | measured by DXA (iDXA; GE Healthcare) | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | change in body composition | measured by DXA (iDXA; GE Healthcare) | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | change in body weight | measured by standardized scale | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | Dietary intake (change in food and nutrient intake) | measured by repeated 24 hour recalls | Measured one and three week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | Change in antioxidant status | e.g. FRAP, ORAC, dROM, isoprostanes measured by HPLC | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | biomarkers of antioxidant-rich foods | e.g. carotenoids, flavonoids measured by HPLC | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | Change in whole blood gene expression | Fasting blood samples (PAX-tubes) and samples taken after physical stress test (PAX-tubes). RNA will be isolated and gene expression measured | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | Change in blood lipids | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | ||
Secondary | Change hormones | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | ||
Secondary | Change in micronutrients | e.g. iron status | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | change response to stress test | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | ||
Secondary | Change in hemoglobin | CO-rebreathing-method | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | change in blood volume | CO-rebreathing-method | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | change in plasma volume | CO-rebreathing-method | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | |
Secondary | Change in lactate | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp | ||
Secondary | Total training load | Training diary | Measured one week before, during (in week 1 and 3 of the camp) and one week after the moderate altitude training camp |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03995979 -
Inflammation and Protein Restriction
|
N/A | |
Completed |
NCT03255187 -
Effect of Dietary Supplemental Fish Oil in Alleviating Health Hazards Associated With Air Pollution
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT03577223 -
Egg Effects on the Immunomodulatory Properties of HDL
|
N/A | |
Completed |
NCT04383561 -
Relationship Between LRG and Periodontal Disease
|
N/A | |
Active, not recruiting |
NCT03622632 -
Pilot Study to Measure Uric Acid in Traumatized Patients: Determinants and Prognostic Association
|
||
Completed |
NCT06216015 -
Exercise Training and Kidney Transplantation
|
N/A | |
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT05529693 -
Efficacy of a Probiotic Strain on Level of Markers of Inflammation in an Elderly Population
|
N/A | |
Recruiting |
NCT05670301 -
Flemish Joint Effort for Biomarker pRofiling in Inflammatory Systemic Diseases
|
N/A | |
Recruiting |
NCT05415397 -
Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
|
Phase 3 | |
Recruiting |
NCT05775731 -
Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers
|
||
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Completed |
NCT03859934 -
Metabolic Effects of Melatonin Treatment
|
Phase 1 | |
Completed |
NCT03429920 -
Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
|
N/A | |
Completed |
NCT06065241 -
Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.
|
N/A | |
Completed |
NCT05864352 -
The Role of Dietary Titanium Dioxide on the Human Gut Microbiome and Health
|
||
Completed |
NCT03318731 -
Efficacy and Safety of Fenugreek Extract on Markers of Muscle Damage and Inflammation in Untrained Males
|
N/A | |
Not yet recruiting |
NCT06134076 -
Comparing Effects of Fermented and Unfermented Pulses and Gut Microbiota
|
N/A | |
Not yet recruiting |
NCT05910489 -
Micro and Nanoplastics in Greenhouse Workers: Biomarkers of Exposure and Effect
|